NIH Scientists Advance Universal Flu Vaccine
A universal influenza vaccine — so-called because it could potentially provide protection from all flu strains for decades — may become a reality because of research led by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
In experiments with mice, ferrets and monkeys, the investigators used a two-step immunization approach to elicit infection-fighting antibodies that attacked a diverse array of influenza virus strains. Current flu vaccines do not generate such broadly neutralizing antibodies, so they must be re-formulated annually to match the predominant virus strains circulating each year.
The research, led by NIAID scientist Gary J. Nabel, M.D., Ph.D., appears online ahead of print July 15 in Science Express.
“Generating broadly neutralizing antibodies to multiple strains of influenza in animals through vaccination is an vital milestone in the quest for a universal influenza vaccine,” says NIAID Director Anthony S. Fauci, M.D. “This significant advance lays the groundwork for the development of a vaccine to provide long-lasting protection against any strain of influenza. A durable and effective universal influenza vaccine would have enormous ramifications for the control of influenza, a disease that claims an estimated 250,000 to 500,000 lives annually, including an average of 36,000 in the United States.”
In parallel experiments with mice, ferrets and monkeys, Dr. Nabel and his colleagues first primed the animals
View the Original article
Related posts:
- NIH Scientists Explore 1510 Influenza Pandemic and Lessons Learned
- NIH Experts Describe Influenza Vaccines of the Future
- Immunity had been ill with H1N1 was universal
- NIH study models H1N1 flu spread
- Vaccine Immunity – Despite nearly 30 years of medical science and over 25 million worldwide deaths, why do we still not have a vaccine to HIV?
Leave a Reply
You must be logged in to post a comment.
